Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2019 Volume 18 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2019 Volume 18 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice

  • Authors:
    • Lukas Horvath
    • David Bächinger
    • Tim Honegger
    • Daniel Bodmer
    • Arianne Monge Naldi
  • View Affiliations / Copyright

    Affiliations: Department of Otorhinolaryngology, Head and Neck Surgery, University of Zurich, University Hospital Zurich, 8091 Zurich, Switzerland, Department of Biomedicine and The Clinic for Otorhinolaryngology, University Hospital Basel, 4031 Basel, Switzerland
    Copyright: © Horvath et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1123-1130
    |
    Published online on: June 18, 2019
       https://doi.org/10.3892/etm.2019.7687
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Aminoglycoside ototoxicity is common in clinical practice but reliable protective agents currently do not exist. Aminoglycoside regimens causing ototoxicity in different laboratory animals are under investigation. The assessment method used most commonly to determine auditory effects is the auditory brainstem response (ABR). Distortion product otoacoustic emissions (DPOAE) have been used less frequently. A precise recommendation on the specific method to assess peripheral auditory function before and after aminoglycoside toxicity in mice does not exist. In order to evaluate various mouse models for ototoxic injury caused by various aminoglycoside regimens, there is a need for performing preliminary tests in small cohorts before large experiments. The aim of our study was to investigate different aminoglycoside regimens that cause substantial ototoxic damage in vivo. Aminoglycosides are safe and produce a detectable hearing threshold shift in a small cohort of mice that can be used as a model for preliminary tests. Different ototoxic regimens were assessed by ABR and DPOAE measurements pre‑ and post‑treatment. Further, the sensory cell loss was quantified by counting hair cells in the cochlea. It was revealed that an ototoxic regimen with kanamycin twice daily for 15 consecutive days is safe, well tolerated and produces an early significant hearing threshold shift detected by DPOAE in a small cohort of mice. The study compared ABR and DPOAE in mentioned regimens for the first time and illustrated that DPOAE is well suited for detecting hearing threshold shifts in high frequencies before ABR threshold shifts occur in accordance with predominating outer hair cell damage mainly in the basal turn of the cochlea.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

World Health Organization, Geneva. WHO Fact sheet 2018. Deafness and hearing loss, . http://www.who.int/mediacentre/factsheets/fs300/en/March 20–2019

2 

Brummett RE and Morrison RB: The incidence of aminoglycoside antibiotic-induced hearing loss. Arch Otolaryngol Head Neck Surg. 116:406–410. 1990. View Article : Google Scholar : PubMed/NCBI

3 

Blakley BW, Hochman J, Wellman M, Gooi A and Hussain AE: Differences in ototoxicity across species. J otolaryngol Head Neck Surg. 37:700–703. 2008.PubMed/NCBI

4 

Guthrie OW: Aminoglycoside induced ototoxicity. Toxicology. 249:91–96. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Murillo-Cuesta S, Contreras J, Cediel R and Varela-Nieto I: Comparison of different aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice. Lab Anim. 44:124–131. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Corrado AP, de Morais IP and Prado WA: Aminoglycoside antibiotics as a tool for the study of the biological role of calcium ions. Historical overview. Acta Physiol Pharmacol Latinoam. 39:419–430. 1989.PubMed/NCBI

7 

Forge A and Schacht J: Aminoglycoside antibiotics. Audiol Neurootol. 5:3–22. 2000. View Article : Google Scholar : PubMed/NCBI

8 

Pichler M, Wang Z, Grabner-Weiss C, Reimer D, Hering S, Grabner M, Glossmann H and Striessnig J: Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry. 35:14659–14664. 1996. View Article : Google Scholar : PubMed/NCBI

9 

Poirrier AL, Van den Ackerveken P, Kim TS, Vandenbosch R, Nguyen L, Lefebvre PP and Malgrange B: Ototoxic drugs: Difference in sensitivity between mice and guinea pigs. Toxicol Lett. 193:41–49. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Walton K, Dorne JL and Renwick AG: Species-specific uncertainty factors for compounds eliminated principally by renal excretion in humans. Food Chem Toxicol. 42:261–274. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Yang B and Bankir L: Urea and urine concentrating ability: New insights from studies in mice. Am J Physiol Renal Physiol. 288:F881–F896. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Chen L, Xiong S, Liu Y and Shang X: Effect of different gentamicin dose on the plasticity of the ribbon synapses in cochlear inner hair cells of C57BL/6J mice. Mol Neurobiol. 46:487–494. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Wu WJ, Sha SH, McLaren JD, Kawamoto K, Raphael Y and Schacht J: Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear Res. 158:165–178. 2001. View Article : Google Scholar : PubMed/NCBI

14 

Steel KP and Bock GR: Hereditary inner-ear abnormalities in animals. Relationships with human abnormalities. Arch Otolaryngol. 109:22–29. 1983. View Article : Google Scholar : PubMed/NCBI

15 

Probst FJ and Camper SA: The role of mouse mutants in the identification of human hereditary hearing loss genes. Hear Res. 130:1–6. 1999. View Article : Google Scholar : PubMed/NCBI

16 

Hartman BH, Basak O, Nelson BR, Taylor V, Bermingham-McDonogh O and Reh TA: Hes5 expression in the postnatal and adult mouse inner ear and the drug-damaged cochlea. J Assoc Res Otolaryngol. 10:321–340. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Hirose K and Sato E: Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea. Hear Res. 272:108–116. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Taylor RR, Nevill G and Forge A: Rapid hair cell loss: A mouse model for cochlear lesions. J Assoc Res Otolaryngol. 9:44–64. 2008. View Article : Google Scholar : PubMed/NCBI

19 

West BA, Brummett RE and Himes DL: Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pigs. Arch Otolaryngol. 98:32–37. 1973. View Article : Google Scholar : PubMed/NCBI

20 

Nourski KV, Miller CA, Hu N and Abbas PJ: Co-administration of kanamycin and ethacrynic acid as a deafening method for acute animal experiments. Hear Res. 187:131–133. 2004. View Article : Google Scholar : PubMed/NCBI

21 

Russell NJ, Fox KE and Brummett RE: Ototoxic effects of the interaction between kanamycin and ethacrynic acid. Cochlear ultrastructure correlated with cochlear potentials and kanamycin levels. Acta Otolaryngol. 88:369–381. 1979. View Article : Google Scholar : PubMed/NCBI

22 

Jansen TT, Bremer HG, Topsakal V, Hendriksen FG, Klis SF and Grolman W: Deafness induction in mice. Otol Neurotol. 34:1496–1502. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Oesterle EC and Campbell S: Supporting cell characteristics in long-deafened aged mouse ears. J Assoc Res Otolaryngol. 10:525–544. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Kendall A and Schacht J: Disparities in auditory physiology and pathology between C57BL/6J and C57BL/6N substrains. Hear Res. 318:18–22. 2014. View Article : Google Scholar : PubMed/NCBI

25 

FELASA working group on revision of guidelines for health monitoring of rodents and rabbits, ; Mähler Convenor M, Berard M, Feinstein R, Gallagher A, Illgen-Wilcke B, Pritchett-Corning K and Raspa M: FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units. Lab Anim. 48:178–192. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Horvath L, Bodmer D, Radojevic V and Monge Naldi A: Activin signaling disruption in the cochlea does not influence hearing in adult mice. Audiol Neurootol. 20:51–61. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Mhatre AN, Li Y, Bhatia N, Wang KH, Atkin G and Lalwani AK: Generation and characterization of mice with Myh9 deficiency. Neuromolecular Med. 9:205–215. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Koay G, Heffner R and Heffner H: Behavioral audiograms of homozygous med(J) mutant mice with sodium channel deficiency and unaffected controls. Hear Res. 171:111–118. 2002. View Article : Google Scholar : PubMed/NCBI

29 

Sedo-Cabezon L, Boadas-Vaello P, Soler-Martin C and Llorens J: Vestibular damage in chronic ototoxicity: A mini-review. Neurotoxicology. 43:21–27. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Versnel H, Agterberg MJ, de Groot JC, Smoorenburg GF and Klis SF: Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide. Hear Res. 231:1–12. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Liu H, Ding DL, Jiang HY, Wu XW, Salvi R and Sun H: Ototoxic destruction by co-administration of kanamycin and ethacrynic acid in rats. J Zhejiang Univ Sci B. 12:853–861. 2011. View Article : Google Scholar : PubMed/NCBI

32 

Ding D, McFadden SL, Browne RW and Salvi RJ: Late dosing with ethacrynic acid can reduce gentamicin concentration in perilymph and protect cochlear hair cells. Hear Res. 185:90–96. 2003. View Article : Google Scholar : PubMed/NCBI

33 

Ohtani I, Ohtsuki K, Omata T, Ouchi J and Saito T: Potentiation and its mechanism of cochlear damage resulting from furosemide and aminoglycoside antibiotics. ORL J Otorhinolaryngol Relat Spec. 40:53–63. 1978. View Article : Google Scholar : PubMed/NCBI

34 

Fausti SA, Rappaport BZ, Schechter MA, Frey RH, Ward TT and Brummett RE: Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: Selected case studies. Am J Otolaryngol. 5:177–182. 1984. View Article : Google Scholar : PubMed/NCBI

35 

Tan CT, Hsu CJ, Lee SY, Liu SH and Lin-Shiau SY: Potentiation of noise-induced hearing loss by amikacin in guinea pigs. Hear Res. 161:72–80. 2001. View Article : Google Scholar : PubMed/NCBI

36 

Aksoy F, Dogan R, Ozturan O, Eren SB, Veyseller B, Pektas A and Hüseyinbas Ö: Protective effect of trimetazidine on amikacin-induced ototoxicity in rats. Int J Pediatr Otorhinolaryngol. 78:663–669. 2014. View Article : Google Scholar : PubMed/NCBI

37 

Aksoy F, Dogan R, Ozturan O, Yildirim YS, Veyseller B, Yenigun A and Ozturk B: Betahistine exacerbates amikacin ototoxicity. Ann Otol Rhinol Laryngol. 124:280–287. 2015. View Article : Google Scholar : PubMed/NCBI

38 

Shi Y and Martin WH: ABR and DPOAE detection of cochlear damage by gentamicin. J Basic Clin Physiol Pharmacol. 8:141–155. 1997. View Article : Google Scholar : PubMed/NCBI

39 

Kakigi A, Hirakawa H, Harel N, Mount RJ and Harrison RV: Comparison of distortion-product and transient evoked otoacoustic emissions with ABR threshold shift in chinchillas with ototoxic damage. Auris Nasus Larynx. 25:223–232. 1998. View Article : Google Scholar : PubMed/NCBI

40 

Peguero B and Tempel BL: A chromosome 17 locus engenders frequency-specific non-progressive hearing loss that contributes to age-related hearing loss in mice. J Assoc Res Otolaryngol. 16:459–471. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Horvath L, Bächinger D, Honegger T, Bodmer D and Monge Naldi A : Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice. Exp Ther Med 18: 1123-1130, 2019.
APA
Horvath, L., Bächinger, D., Honegger, T., Bodmer, D., & Monge Naldi, A. . (2019). Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice. Experimental and Therapeutic Medicine, 18, 1123-1130. https://doi.org/10.3892/etm.2019.7687
MLA
Horvath, L., Bächinger, D., Honegger, T., Bodmer, D., Monge Naldi, A. ."Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice". Experimental and Therapeutic Medicine 18.2 (2019): 1123-1130.
Chicago
Horvath, L., Bächinger, D., Honegger, T., Bodmer, D., Monge Naldi, A. ."Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice". Experimental and Therapeutic Medicine 18, no. 2 (2019): 1123-1130. https://doi.org/10.3892/etm.2019.7687
Copy and paste a formatted citation
x
Spandidos Publications style
Horvath L, Bächinger D, Honegger T, Bodmer D and Monge Naldi A : Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice. Exp Ther Med 18: 1123-1130, 2019.
APA
Horvath, L., Bächinger, D., Honegger, T., Bodmer, D., & Monge Naldi, A. . (2019). Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice. Experimental and Therapeutic Medicine, 18, 1123-1130. https://doi.org/10.3892/etm.2019.7687
MLA
Horvath, L., Bächinger, D., Honegger, T., Bodmer, D., Monge Naldi, A. ."Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice". Experimental and Therapeutic Medicine 18.2 (2019): 1123-1130.
Chicago
Horvath, L., Bächinger, D., Honegger, T., Bodmer, D., Monge Naldi, A. ."Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice". Experimental and Therapeutic Medicine 18, no. 2 (2019): 1123-1130. https://doi.org/10.3892/etm.2019.7687
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team